TBC

( DrugBank: - / KEGG DRUG: - )


4 diseases
IDDisease name (Link within this page)Number of trials
85Idiopathic interstitial pneumonia1
94Primary sclerosing cholangitis2
IDDisease name (Link within this page)Number of trials
96Crohn disease1
127Frontotemporal lobar degeneration2

85. Idiopathic interstitial pneumonia


Clinical trials : 723Drugs : 411 - (DrugBank : 126) / Drug target genes : 104 - Drug target pathways : 212 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

94. Primary sclerosing cholangitis


Clinical trials : 177Drugs : 120 - (DrugBank : 48) / Drug target genes : 25 - Drug target pathways : 148 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

96. Crohn disease


Clinical trials : 2,737Drugs : 1,197 - (DrugBank : 240) / Drug target genes : 182 - Drug target pathways : 221 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

127. Frontotemporal lobar degeneration


Clinical trials : 123Drugs : 107 - (DrugBank : 33) / Drug target genes : 49 - Drug target pathways : 89 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries